Search for Clinical Trial Results
Dwarfism - 50 Studies Found
Status | Study |
Completed |
Study Name: Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin Condition: Idiopathic Short Stature Date: 2007-06-18 Interventions: Drug: somatropin (Genotropin® treatment) 0,035 mg /kg bodyweight of Somatropin per day given by sub |
Completed |
Study Name: rhGH Therapy on Hepatic Drug Metabolism Condition: Growth Hormone Deficiency, Dwarfism Date: 2007-04-09 Interventions: Drug: Dextromethorphan and Caffeine All subjects received standard medical therapy with rhGH and at spec |
Completed |
Study Name: A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood Condition:
Date: 2010-07-06 Interventions:
|
Terminated |
Study Name: Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature Condition:
Date: 2005-07-14 Interventions: Drug: somatropin (rDNA) Form/Strength: 10 mg aqueous suspe |
Completed |
Study Name: Individualizing Dose of Growth Hormone to Maintain Normal Growth Velocity After Fulfilled Catch up Growth in Children Condition: Short Stature Date: 2016-08-10 Interventions: Drug: Genotropin Children were randomized to either decreased dose by 50% or unchanged dose after 2-3 ye |
Completed |
Study Name: Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen® Condition: Dwarfism, Pituitary Date: 2010-08-22 Interventions: Drug: Recombinant human growth hormone (r-hGH) Recombinant human growth hormone (r-hGH) administered at |
Recruiting |
Study Name: Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children Condition: Dwarfism, Pituitary Date: 2014-11-27 Interventions: Biological: PEG-somatropin |
Completed |
Study Name: National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients Condition: Dwarfism, Pituitary Date: 2004-11-24 |
Completed |
Study Name: Consequence of Lifetime Isolated Growth Hormone Deficiency Condition: Growth Hormone Deficiency Date: 2005-09-06 Interventions: Drug: growth hormone administration for 6 months depot GH (Nutropin depot) 13.4 mg every 14 days |
Terminated |
Study Name: Efficacy of Somatropin in Adult Patients With Isolated Growth Hormone Deficiency Condition: Growth Hormone Deficiency Date: 2008-02-28 Interventions:
|